NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced that it will host its 3rd Annual Healthcare Day on Wednesday, June 22, 2016 at the Dorchester Hotel in London, U.K.
ROTH’s Healthcare Day will give investors the opportunity to interact with senior management of a select group of Life Sciences companies focused in the Biotechnology, Medical Technologies and Specialty Pharmaceuticals sectors.
The event will allow for extensive interaction and on-on-one meetings with management teams, providing in-depth insights into each company.
ROTH Biotechnology Senior Research Analysts Joe Pantginis, Ph.D., and Specialty Pharmaceuticals Senior Research Analysts Scott Henry, CFA, and Michael Higgins, as well as Chris Lewis, Senior Research Analyst – Medical Technologies, will be available to discuss their perspectives regarding the companies attending and their views regarding the current healthcare market trends.
“The Life Sciences sector has achieved significant clinical advancement and growth over the past several years. However, the sector has become much more volatile over the past several months due to issues around pricing and reimbursement, intellectual property and the upcoming election,” commented John W. Chambers, Vice Chairman and Head of Healthcare Investment Banking at ROTH. “Currently with over 600 publicly traded Life Sciences companies – largely due to the healthy volume of IPOs over the past several years - and with an aggregate market cap encroaching on $1 trillion the sector has become highly visible to the investment community. This event is designed to provide investors with direct interactions with the management teams of a select group of high quality companies from early to late stage development, through commercialization and to enable those investors to further understand their scientific approach, clinical achievements to date and upcoming milestones and catalysts. This event comprising exclusively one-on-one meetings will allow investors the opportunity to gain direct insight into the key value drivers for this group of innovative companies.”
ROTH has built a leading Healthcare Investment Banking Group over the last several years and has raised approximately $11.5 billion in over 320 Healthcare transactions since 2010. *Past Performance is not indicative of future returns. (Source: ROTH Capital 06/10/2016)
The event is for institutional clients of ROTH and is by invitation only. For more information, please contact your ROTH sales representative at (949) 720-5700 or e-mail: conference@roth.com.
Agenda and Events
Tuesday | June 21, 2016
5:00 pm - 7:00 pm | Cocktail
Reception
Wednesday | June 22, 2016
8:00 am - 9:00 am | Morning Coffee
12:00
pm – 1:00 pm | Lunch
9:00 am - 5:00 pm | 1-on-1 / Small Group
Meetings
Venue:
The Dorchester
53 Park Lane, Mayfair
London,
W1K 1QA, UK
Tel: +44 (0) 20-7629-8888
Participating Companies
The following participating
companies are confirmed as of the date of this release:
|
Company Name |
| AcelRx Pharmaceuticals, Inc. (ACRX) |
| Aduro Biotech, Inc. (ADRO) |
| Alcobra Ltd. (ADHD) |
| Capricor Therapeutics, Inc. (CAPR) |
| Cytokinetics, Inc. (CYTK) |
| Evotec AG (XTRA:EVT) |
| Flex Pharma (FLKS) |
| Fortress Biotech, Inc. (FBIO) |
| iRadimed Corp. (IRMD) |
| Juniper Pharmaceuticals (JNP) |
| Ligand Pharmaceuticals, Inc. (LGND) |
| Lion Biotechnologies, Inc. (LBIO) |
| MacroGenics, Inc. (MGNX) |
| Nektar Therapeutics (NKTR) |
| Neuralstem, Inc. (CUR) |
| NeuroDerm Ltd. (NDRM) |
| Oramed Pharmaceuticals Inc. (ORMP) |
| Oxford BioMedica (LSE:OXB) |
| Pieris Pharmaceuticals, Inc. (PIRS) |
| RedHill Biopharma Ltd. (RDHL) |
| Spark Therapeutics, Inc. (ONCE) |
| Strongbridge Biopharma plc (SBBP) |
| Sucampo Pharmaceuticals, Inc. (SCMP) |
| Titan Pharmaceuticals, Inc. (TTNP) |
|
Tonix Pharmaceuticals Holding Corp.
(TNXP) |
| Zosano Pharma Corp. (ZSAN) |
| Zynerba Pharmaceuticals, Inc. (ZYNE) |
Event sponsors include Business Wire, Equisolve and Lowenstein Sandler.
About ROTH Capital Partners, LLC:
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S. and Hong Kong. For more information on ROTH, please visit www.roth.com.
